TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Hishiki, T. [1 ]
Horie, H. [2 ]
Higashimoto, Y. [1 ]
Yotsumoto, K. [1 ]
Komatsu, S. [1 ]
Okimoto, Y. [3 ]
Kakuda, H. [3 ]
Taneyamai, Y. [3 ]
Yoshida, H. [4 ]
Iwai, J. [1 ]
机构：
[1] Chiba Childrens Hosp, Dept Pediat Surg, Chiba, Japan
[2] Chiba Childrens Hosp, Dept Pathol, Chiba, Japan
[3] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-348
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [41] High-dose chemotherapy with autologous or allogeneic hematopoietic stem cell transplantation for high-risk neuroblastoma patients, a single transplant center experience
    Kazantsev, Ilya
    Gevorgian, Asmik
    Iukhta, Tatiana
    Tolkunova, Polina
    Kozlov, Andrew
    Andreeva, Tatiana
    Morozova, Elena
    Litvinov, Andrey
    Kuga, Polina
    Safonova, Svetlana
    Punanov, Yuri
    Zubarovskaya, Liudmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 558 - 559
  • [42] FACTORS RELATED TO GROWTH RETARDATION IN LONG-TERM HIGH-RISK NEUROBLASTOMA SURVIVORS TREATED WITH HIGH-DOSE CHEMOTHERAPY
    Haghiri, Sandrine
    Karamouza, Eleni
    Fayech, Chiraz
    Thebault, Eric
    Allard, Julie
    Thomas-Teinturier, Cecile
    Dufour, Christelle
    Bolle, Stephanie
    Haddy, Nadia
    De Vathaire, Florent
    Valteau-Couanet, Dominique
    Le Teuff, Gwenael
    Fresneau, Brice
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S487 - S488
  • [43] Therapeutic effects of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for high-risk advanced neuroblastoma
    Mao, Lei
    Xia, Bing
    Yang, Hongliang
    Wang, Yafei
    Yu, Yong
    Wang, Xiaofeng
    Zhao, Zhigang
    Wang, Jingfu
    Li, Jie
    Li, Zhanglin
    Zhao, Qiang
    Yan, Jie
    Zhang, Yizhuo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 738 - 739
  • [44] The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma
    Park, Hyun Jin
    Choi, Jung Yoon
    Kim, Bo Kyung
    Hong, Kyung Taek
    Kim, Hyun-Young
    Kim, Il Han
    Cheon, Gi Jeong
    Cheon, Jung-Eun
    Park, Sung-Hye
    Kang, Hyoung Jin
    CHILDREN-BASEL, 2023, 10 (12):
  • [45] Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy
    Yanishevski, David
    McCarville, M. Beth
    Doubrovin, Mikhail
    Spiegl, Hannah R.
    Zhao, Xiwen
    Lu, Zhaohua
    Federico, Sara M.
    Furman, Wayne L.
    Murphy, Andrew J.
    Davidoff, Andrew M.
    JOURNAL OF PEDIATRIC SURGERY, 2020, 55 (01) : 130 - 134
  • [46] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [47] High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy
    Ola El Kebbi
    Cassandra S. Prather
    Lena Elmuti
    Malak Khalifeh
    Muayad Alali
    Scientific Reports, 13
  • [48] High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy
    El Kebbi, Ola
    Prather, Cassandra S.
    Elmuti, Lena
    Khalifeh, Malak
    Alali, Muayad
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] Idiopathic hyperammonemia following high-dose chemotherapy
    Espinós, J
    Rifón, J
    Pérez-Calvo, J
    Nieto, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 (09) : 899 - 899
  • [50] Idiopathic hyperammonemia following high-dose chemotherapy
    J Espinós
    J Rifón
    J Pérez-Calvo
    Y Nieto
    Bone Marrow Transplantation, 2006, 37 : 899 - 899
12345